2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
8
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Ovarian Neoplasms
2
Lung Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Peripheral Nervous System Diseases
1
Pain
1
Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Diseases
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Cachexia
1
Cachexia
1
Breastcancer
1
Breast Carcinoma In Situ
1
Biliary Tract Neoplasms
1
Interventions
Megestrol Acetate
9
Exercise
6
Standard of Care
4
Blood Specimen Collection
4
Olanzapine
3
Ibuprofen
3
dermcidin
2
anamorelin
2
Resistance Training
2
Physical Therapy Modalities
2
Nutrition Assessment
2
Mirtazapine
2
Melatonin
2
Infliximab
2
Enteral Nutrition
2
Dietary Supplements
2
Diet Therapy
2
Cyproheptadine
2
testosterone enanthate
1
telotristat ethyl
1
remune
1
ostarine
1
olanzapine-fluoxetine combination
1
nabiximols
1
nabilone
1
irinotecan sucrosofate
1
fucoidan
1
clazakizumab
1
bermekimab
1
alkaloid GB18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cachexia
×
Omacor
×
Clear all
NCT04907864
2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2
Unknown
112 enrolled